Rothschild & Co Asset Management US’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHC
Rothschild & Co Asset Management US's ACHC Position: Q4 2022 in Review
Rothschild & Co Asset Management US reduced its Acadia Healthcare (ACHC) stake by 9.6% in Q4 2022, selling an estimated $515K and leaving 58,674 shares worth $4.83M. The position accounts for 0.07% of the portfolio, ranked #184.
Rothschild & Co Asset Management US first reported a position in ACHC in Q1 2018 and has held it in 20 quarters since. The position peaked at $39.3M in Q2 2018. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.
- Rothschild & Co Asset Management US held 58,674 shares of Acadia Healthcare worth $4.83M as of Q4 2022.
- Rothschild & Co Asset Management US sold 6,253 Acadia Healthcare shares in Q4 2022, an estimated $515K.
- Acadia Healthcare made up 0.07% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #184 holding.
- Rothschild & Co Asset Management US first reported a position in Acadia Healthcare in Q1 2018 and has held it in 20 quarters since.
- Rothschild & Co Asset Management US's Acadia Healthcare position peaked at $39.3M in Q2 2018.
- 346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.